Skip to main content
Journal cover image

Identification of neurogenetic pathways of risk for psychopathology.

Publication ,  Journal Article
Fisher, PM; Muñoz, KE; Hariri, AR
Published in: American journal of medical genetics. Part C, Seminars in medical genetics
May 2008

Imaging genetics has been a highly effective and increasingly applied strategy for identifying the impact of genetic polymorphisms on individual differences in neural circuitry supporting complex behaviors. The application of imaging genetics towards further elucidating neural circuitry associated with the pathophysiology of psychiatric illness is of particular interest given its potential to guide the development and improvement of current therapeutic methods. The identification of genetic variants that contribute to or predict the disruption of specific neural pathways associated with psychopathology may also serve as useful markers of risk demarcating individuals with elevated susceptibility for psychiatric illness and affording early or even preemptive treatment strategies. In the continued development of this technique, recent multimodal neuroimaging strategies and studies examining the effects of multiple genes in concert within large subject populations have shown promise in the development of a more complete understanding of the interrelationships between genes, brain function, behavior and associated risk for psychopathology.

Duke Scholars

Published In

American journal of medical genetics. Part C, Seminars in medical genetics

DOI

EISSN

1552-4876

ISSN

1552-4868

Publication Date

May 2008

Volume

148C

Issue

2

Start / End Page

147 / 153

Related Subject Headings

  • Tryptophan Hydroxylase
  • Serotonin Plasma Membrane Transport Proteins
  • Risk Factors
  • Psychopathology
  • Monoamine Oxidase
  • Mental Disorders
  • Male
  • Humans
  • Genetics & Heredity
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fisher, P. M., Muñoz, K. E., & Hariri, A. R. (2008). Identification of neurogenetic pathways of risk for psychopathology. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 148C(2), 147–153. https://doi.org/10.1002/ajmg.c.30173
Fisher, Patrick M., Karen E. Muñoz, and Ahmad R. Hariri. “Identification of neurogenetic pathways of risk for psychopathology.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 148C, no. 2 (May 2008): 147–53. https://doi.org/10.1002/ajmg.c.30173.
Fisher PM, Muñoz KE, Hariri AR. Identification of neurogenetic pathways of risk for psychopathology. American journal of medical genetics Part C, Seminars in medical genetics. 2008 May;148C(2):147–53.
Fisher, Patrick M., et al. “Identification of neurogenetic pathways of risk for psychopathology.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, vol. 148C, no. 2, May 2008, pp. 147–53. Epmc, doi:10.1002/ajmg.c.30173.
Fisher PM, Muñoz KE, Hariri AR. Identification of neurogenetic pathways of risk for psychopathology. American journal of medical genetics Part C, Seminars in medical genetics. 2008 May;148C(2):147–153.
Journal cover image

Published In

American journal of medical genetics. Part C, Seminars in medical genetics

DOI

EISSN

1552-4876

ISSN

1552-4868

Publication Date

May 2008

Volume

148C

Issue

2

Start / End Page

147 / 153

Related Subject Headings

  • Tryptophan Hydroxylase
  • Serotonin Plasma Membrane Transport Proteins
  • Risk Factors
  • Psychopathology
  • Monoamine Oxidase
  • Mental Disorders
  • Male
  • Humans
  • Genetics & Heredity
  • Female